Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage

Acta Neurochirurgica

Volumn 141, Issue 12, 1999, Pages 1323-1329

  Kiris T ^a   Karasu, A ^b   Yavuz, C ^a   Erdem, T ^a   Unal F ^a   Hepgul K ^a   Baloglu, H ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bakirkoy State Hospital   (Turkey)

Author keywords

Cerebral vasospasm; Nitric oxide; S nitroso N acetylpenicillamine; Subarachnoid haemorrhage

Indexed keywords

N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXYHEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VASOSPASM;

ANIMALS; ENDOTHELIUM, VASCULAR; MALE; NITRIC OXIDE DONORS; PENICILLAMINE; RABBITS; SUBARACHNOID HEMORRHAGE; VASCULAR RESISTANCE; VASOSPASM, INTRACRANIAL;

EID: 0033404089     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050437     Document Type: Article

References (48)

1. 1. Afshar JKB, Pluta RM, Boock RJ, Thompson BG, Oldfield EH (1995) Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83: 118-122
2. 2. Angus JA, Cocks TM (1989) Endothelium-derived relaxing factor. Pharmacol Ther 41: 303-352
3. 3. Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassel NF, Lee KS (1996) Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 85: 917-922
4. 4. Egemen N, Türker RK, Şanlidilek U, Zorlutuna A, Bilgiç S, Başkaya M, Ünlü A, Çaglar S, McCormick JM, Spetzler RF (1993) The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 15: 310-315
5. 5. Findlay JM, Weir BKA, Kanamaru K, Espinosa F (1989) Arterial wall changes in cerebral vasospasm. Neurosurgery 25: 736-746
6. 6. Frazee JG, Giannotta SL, Stern E (1981) Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg 55: 865-868
7. 7. Fukatsu K, Saito H, Han I, Furukawa S, Lin MT, Matsuda T, Ikeda S, Inoue T, Yasuhara H, Muto T (1998) Nitric oxide donor decreases neutrophil adhesion in both lung and peritoneum during peritonitis. J Surg Res 74(2): 119-124
8. 8. Fuji S, Fujitsu K (1988) Experimental vasospasm in cultured arterial smooth-muscle cells. Part I: Contractile and ultra-structural changes caused by oxyhemoglobin. J Neurosurg 69: 92-97
9. 9. Fujiwara S, Kassel NF, Sasaki T, Nakagomi T, Lehman RM (1986) Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg 64: 445-452
10. 10. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetyl-choline. Nature 288: 373-376
11. 11. Haley EC Jr, Kassel NF, Torner JC: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report on the cooperative aneurysm study (1993) J Neurosurg 78: 537-547
12. 12. Heros RC, Zervas NT, Lavyne MH, Pickren KP (1976) Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol 6: 227-229
13. 13. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, Vollmer DG, Lehman RM (1988) Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 69: 247-253
14. 14. Hongo K, Ogawa H, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Lehman RM (1988) Comparison of intraluminal and extraluminal inhibitory effects of hemoglobin on endothelium-dependent relaxation of rabbit basilar artery. Stroke 19: 1550-1555
15. 15. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269
16. 16. Ignarro LJ, Byrns RE, Buga GM, et al (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of the nitric oxide radical. Circ Res 61: 866-879
17. 17. Ignarro LJ (1989) Endothelium derived nitric oxide: actions and properties. FASEB J 3: 31-36
18. 18. Ignarro LJ (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30: 535 560
19. 19. Johshita H, Kassell NF, Sasaki T, Nakagomi T, Ogawa H (1992) Biphasic constriction of rabbit basilar artery following experimental subarachnoid hemorrhage: A morphometric study. Surg Neurol 37: 106-114
20. 20. Kassel NF, Torner JC, Haley EC Jr, et al (1990) The international study on timing of aneurysm surgery. Part I. Overall management results. J Neurosurg 73: 18-36
21. 21. Kim P, Sundt TM Jr, Vanhoutte PM (1988) Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg 69: 239-246
22. 22. Kontos H (1993) Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke 24 [Suppl] 12: 1155 1158
23. 23. Kowaluk EA, Fung HL (1990) Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 255: 1256 1264
24. 24. Ku DD (1996) Nitric oxide and nitric oxide donor induced relaxation. Methods Enzymol 269: 107-119
25. 25. Kwan AL, Bavbek M, Jeng AY, Maniara W, Toyoda T, Lappe RW, Kassel NF, Lee KS (1987) Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg 87: 281-286
26. 26. MacDonald RL, Weir BKA (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971 982
27. 27. Martin W, Villani GM, Jothianandan D, Furchgott RF (1985) Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J Pharmacol Exp Ther 233: 679 685
28. 28. Mathews NR, Kerr SW (1993) The biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther 267: 1529-1537
29. 29. Mayberg MR, Okada T, Bark DH (1990): The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 72: 634-640
30. 30. Mayberg MR, Okada T, Bark DH (1990) The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg 72: 626 633
31. 31. Myers PR, Minor RL, Guerra Jr R, Bates JN, Harrison DG (1990) Vasorelaxant properties of the endothelium derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163
32. 32. Nakagomi T, Kassell NF, Sasaki T, Lehman RM, Torner JC, Hongo K, Lee JH (1988) Effect of removal of the endothelium on vasocontraction in canine and rabbit basilar arteries. J Neurosurg 68: 757-766
33. 33. Ohlstein EH, Storer BL (1992) Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77: 274-278
34. 34. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327: 524-526
35. 35. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humprey PR, Lang DA, Nelson R, Richards P and contributors (1989). Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J 298: 636-642
36. 36. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH (1996) Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84: 648 654
37. 37. Pluta RM, Oldfield EH, Boock RJ (1997) Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87: 746 751
38. 38. Radomski MW, Palmer RMJ, Moncada S (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92: 181-187
39. 39. Rubanyi GM, Johns A, Wilcox D, Bates FN, Harrison D (1991) Evidence that a S-nitrosothiol, but not nitric oxide, may be identical with endothelium-derived relaxing factor. J Cardiovasc Pharmacol 17 [Suppl] 3: S41 S45
40. 40. Shaffer JE, Han BJ, Chern WH, Lee FW (1991) Lack of toleranceto a 24-hour infusion of S-nitroso-N-acetylpenicillamine (SNAP) in conscious rabbits. J Pharmacol Exp Ther 260: 286-293
41. 41. Tanaka Y, Chiba S (1988) Relationship between extraluminal oxyhemoglobin and endothelium-dependent vasodilatation in isolated perfused canine internal carotid arteries. Neurosurgery 23: 158-161
42. 42. Thompson BG, Pluta RM, Girton ME, Oldfield EH (1996) Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 84: 71-78
43. 43. Toyoda T, Kwan AL, Bavbek M, Kassel NF, Wanebo JE, Lee KS (1998) Enhanced endogenous antioxidant activity and inhibition of cerebral vasospasm in rabbits by pretreatment with a nontoxic endotoxin analog, monophosphoryl lipid A. J Neurosurg 88: 1082 1087
44. 44. van Gelderen EM, De Burijne ELE, Agteresch HJ, Saxena PR (1995) The effect of nitric oxide donors on haemodynamics and blood flow distribution in the porcine carotid circulation. Br J Pharmacol 114: 1303 1309
45. 45. Vermeulen M, van Gijn J, Blijenberg BG (1983) Spectrophotometric analysis of CSF after subarachnoid hemorrhage: Limitation in the diagnosis of rebleeding. Neurology 33: 112-114
46. 46. Weir B (1995) The pathophysiology of cerebral vasospasm. Br J Neurosug 9: 375 390
47. 47. Wolf EW, Banerjee A, Soble-Smith J, Dohan Jr FC, White RP, Robertson JT (1998) Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89: 279-288
48. 48. Zabramski JM, Hamilton MG (1995) Cerebral vasospasm. In: Carter LP, Spetzler RF (eds) Neurovascular surgery. McGraw-Hill, New York, pp 583-601